Medline Inc. (MDLN) vs Repligen Corporation (RGEN)

Medline Inc. and Repligen Corporation are both Medical Instruments & Supplies companies. Medline Inc. is the larger, with a market value of $45.5B against $10.8B — 4.2× the size. Repligen Corporation has the higher net margin (5.29% vs 2.37%) and the lower return on invested capital (2.18% vs 19.9%). Across the 16 metrics below, Medline Inc. leads on 9 and Repligen Corporation on 7.

Valuation

Metric MDLN RGEN Medical Instruments & Supplies median
P/E — 252.91 34.17
P/S 1.00 13.63 2.83
P/B 1.56 5.07 2.82
Price to free cash flow 12.91 175.18 25.69
EV/EBITDA 3.95 65.28 16.08
EV/Sales 1.33 13.39 3.06
Earnings yield — 0.40% (1.84%)
Free cash flow yield 7.75% 0.57% 0.17%

Profitability

Metric MDLN RGEN Medical Instruments & Supplies median
Gross margin 46.27% 53.52% 54.62%
Operating margin 31.12% 8.23% 1.64%
Net margin 2.37% 5.29% 0.00%
Free cash flow margin 7.75% 14.06% 1.61%
Return on equity 0.00% 1.99% 0.00%
Return on assets 3.58% 1.42% 0.00%
Return on invested capital 19.94% 2.18% 0.00%

Growth

Metric MDLN RGEN Medical Instruments & Supplies median
Revenue growth (TTM) — 16.49% 9.20%
EPS growth (last fiscal year) — 286.96% —
Revenue growth, 5-year CAGR — 15.05% 9.48%
Net income growth, 5-year CAGR — (3.99%) 0.00%

Health

Metric MDLN RGEN Medical Instruments & Supplies median
Debt to equity 0.66 0.26 0.08
Current ratio 4.33 9.05 2.49
Net debt to EBITDA 3.24 (1.50) 0.83

Dividend

Metric MDLN RGEN Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio — 0.00 0.00

Size

Metric MDLN RGEN Medical Instruments & Supplies median
Market cap 45.52b 10.76b 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack